A+
|
A
|
A-
|
Skip to main content
|
IPO
LOGIN
OPEN A DEMAT ACCOUNT
IPO
Login
Open a
Demat
Account
HOME
ABOUT US
PRODUCTS
Equity
Currency
Commodity
IPO
Mutual Funds
PMS
SLBM
SERVICES
Investment Banking
Institutional Equities
Wealth Management
Depository
TRADE WITH SYSTEMATIX
Partner With Us
Trading Simplified
Payment Gateway
Link UPI
KYC Updation
ReKYC
(Document Reactivation/Modification in Account/Nominee Registration/Account Closure)
Bank Details
Account Opening Process
Incapacitated investor
RESEARCH
MARKETS
Overview
Equity
IPO
Mutual Funds
Commodity
Company Info
INVESTORS
Investor Login
Investor Relations
Investor Grievances
ODR
Scores
Downloads
Investor Charter
Information to Physical Shareholders
Procedure for Filing a Complaint
Investor Education
CONTACT US
Our Reach
Careers
OPEN A DEMAT ACCOUNT
HOME
ABOUT US
PRODUCTS
EQUITY
CURRENCY
COMMODITY
IPO
MUTUAL FUND
PMS
SLBM
SERVICES
INVESTMENT BANKING
INSTITUTIONAL EQUITIES
WEALTH MANAGEMENT
DEPOSITORY
TRADE WITH SYSTEMATIX
PARTNER WITH US
TRADING SIMPLIFIED
PAYMENT GATEWAY
LINK UPI
KYC UPDATION
ReKYC (Document Reactivation/Modification in Account/Nominee Registration/Account Closure)
BANK DETAILS
ACCOUNT OPENING PROCESS
Incapacitated investor
RESEARCH
MARKETS
OVERVIEW
EQUITY
IPO
MUTUAL FUND
COMMODITY
COMPANY INFO
INVESTORS
INVESTOR LOGIN
INVESTOR RELATIONS
INVESTOR GRIEVANCES
ODR
SCORES
DOWNLOADS
INVESTOR CHARTER
INFORMATION TO PHYSICAL SHAREHOLDERS
PROCEDURE FOR FILING A COMPLAINT
Investor Education
CONTACT US
OUR REACH
CAREERS
Equity
Mutual Fund
IPO Analysis
Daily Market Tracker
Gainers & Losers
Value & Volume Toppers
52 Week Highs & Lows
New Highs & Lows
Buyers & Sellers
Out/Under Performers
Bulk Deals
Block Deals
Unusual Volume
Rising Volume
Exchange Holidays
5 Days Up & Down
Index Movers
Index Overview
Top Sectors
News & Analysis
Pre Session Commentary
Mid Session Commentary
End Session Commentary
Quick Review
Market Beat
Stock Alert
Hot Pursuit
Foreign Markets
Economy News
Corporate News
Corporate Results
Other Markets
Futures Markets
Corporate Information
Company Snapshot
Company Background
Board Of Directors
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Previous Quarter Comp
Director's Report
Score Board
Mutual Fund Holdings
Announcements
Peer Comparison
Technical Chart
Corporate Actions
Announcements
Book Closure
Board Meetings
Bonus Issues
Rights Issues
Delisted Shares
Market Turnover
Name Change
Split Of Face Value
Event Calendar
Other Markets
ADR Prices
FII Investments
MF Investments
Forex Details
World Indices
GDR Prices
Equity
Commodity
Mutual Fund
IPO
Price Analysis
Volume Analysis
News Analysis
Market Option
Other Option
Company Information
Gainers & Losers
52 Week High Low
News Highs and Low
Advances & Declines
Home
Market Info
Corporate Information
Company Snapshot
Company Snapshot
BSE
Fredun Pharmaceuticals Ltd
BSE Code
539730
ISIN Demat
INE194R01017
Book Value (₹)
443.74
Div & Yield %
0.04
Market Cap (
₹
Cr.)
833.56
P/E *
24.48
EPS *
63.45
Face Value (₹)
10
* Profit to Earning Ratio
* Earning Per Share
Stock Price Details
Last Price (₹)
1,526.00
Change
-19.25 (-1.24%)
Best Buy (₹)
0.00
Best Sell (₹)
0.00
Today's Range
1,526.00 - 1,558.80
52-Week Range
635.05 - 1,999.00
Beta (1 Year)
0.75
Chart
1 Day
|
5 Day
|
3 Month
|
1 Year
|
5 Year
Corporate Announcements
Fredun Pharmaceuticals standalone net profit rises 96.62% in the December 2025 quarter
Fredun Pharmaceuticals to convene board meeting
Fredun Pharmaceuticals to convene EGM
Fredun Pharmaceuticals raises funds via preferential issue of shares and warrants
Fredun Pharmaceuticals standalone net profit rises 127.87% in the September 2025 quarter
Fredun Pharmaceuticals to announce Quarterly Result
Fredun Pharmaceuticals launches ‘Snacky Jain' for pets
Fredun Pharma gains after launching new product
Fredun Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Fredun Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Corporate Details
Incorporation Year :
1987
Chairman :
Daulat N Medhora
Ownership Group :
Indian Private
Sector :
Pharmaceuticals
Industry :
Pharmaceuticals - Indian - Formulations
Registered Office :
Fredun Pharmaceuticals Ltd
26 Manoj Industrial Premises,
G D Ambedkar Marg Wadala,
Mumbai,
Maharashtra - 400031,
Phone : 91-22-40318111,
Fax : N.A.
E-Mail :
business@fredungroup.com
URL :
http://www.fredungroup.com
Investor Returns
Period
Date
Price
Returns (%)
1Week
27-Feb-2026
1,624.45
-5.56
1Month
06-Feb-2026
1,648.00
-6.91
3Month
08-Dec-2025
1,780.70
-13.85
6Month
08-Sep-2025
1,325.30
15.76
1Year
06-Mar-2025
672.55
128.11
Mutual Funds Holding
Scheme Name
% Holding
Market Value
No Data Found
Peerset : Pharmaceuticals - Indian - Formulations
Company
Last Price (₹)
Change (%)
52Week High (₹)
52Week Low (₹)
Market Cap (₹ Cr.)
Torrent Pharmaceuticals Ltd
4,308.05
-1.04
4,469.35
2,978.75
145,803.99
Ajanta Pharma Ltd
2,990.90
0.55
3,052.20
2,022.05
37,367.00
Gland Pharma Ltd
1,669.00
-2.11
2,130.00
1,200.00
27,497.85
ERIS Lifesciences Ltd
1,360.10
-0.66
1,909.55
1,187.10
18,840.55
Caplin Point Laboratories Ltd
1,665.70
1.28
2,396.95
1,551.05
12,661.27
Index Details